Vitamin D and Pre-Eclampsia: Original data, systematic review and meta-analysis

Annals of Nutrition and Metabolism

Volumn 63, Issue 4, 2014, Pages 331-340

  Hyppönen, Elina ^a,b,c   Cavadino, Alana ^c   Williams, David ^d   Fraser, Abigail ^e   Vereczkey, Attila ^g   Fraser, William D ^f   Bánhidy, Ferenc ^h   Lawlor, Deborah ^e   Czeizel, Andrew E ⁱ  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b SOUTH AUSTRALIAN HEALTH AND MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^e UNIVERSITY OF BRISTOL   (United Kingdom)

^f UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^g Versys Clinics   (Hungary)

^h SEMMELWEIS UNIVERSITY   (Hungary)

ⁱ FOUNDATION FOR THE COMMUNITY CONTROL OF HEREDITARY DISEASES   (Hungary)

Author keywords

25 Hydroxyvitamin D; Pre eclampsia; Supplementation; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; VITAMIN D;

CARDIOVASCULAR FUNCTION; COCHRANE LIBRARY; DISEASE ASSOCIATION; EMBASE; HUMAN; IMMUNOMODULATION; MEDLINE; META ANALYSIS; MOTHER; OBSERVATIONAL STUDY; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; VITAMIN SUPPLEMENTATION; BLOOD; DIET SUPPLEMENTATION; FEMALE; NUTRITIONAL STATUS; PRE-ECLAMPSIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); PARITY;

DIETARY SUPPLEMENTS; FEMALE; HUMANS; NUTRITIONAL STATUS; OBSERVATIONAL STUDY AS TOPIC; PRE-ECLAMPSIA; PREGNANCY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; VITAMIN D;

EID: 84895671904     PISSN: 02506807     EISSN: 14219697     Source Type: Journal    
DOI: 10.1159/000358338     Document Type: Review

References (53)

1. Roberts JM, Cooper DW: Pathogenesis and genetics of pre-eclampsia. Lancet 2001; 357: 53-56. (Pubitemid 32056505)
2. Duley L: The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009; 33: 130-137.
3. Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF: WHO analysis of causes of maternal death: a systematic review. Lancet 2006; 367: 9.
4. Hypponen E: Vitamin D for the prevention of preeclampsia? A hypothesis. Nutr Rev 2005; 63: 225-232. (Pubitemid 41003824)
5. Holmes VA, Barnes MS, Alexander HD, Mc-Faul P, Wallace JM: Vitamin D deficiency and insufficiency in pregnant women: a longitudinal study. Br J Nutr 2009; 102: 876-881.
6. Hypponen E: Preventing vitamin D deficiency in pregnancy: importance for the mother and child. Ann Nutr Metab 2011; 59: 28-31.
7. Zehnder D, Evans KN, Kilby MD, Bulmer JN, Innes BA, Stewart PM, Hewison M: The ontogeny of 25-hydroxyvitamin D(3) 1alphahydroxylase expression in human placenta and decidua. Am J Pathol 2002; 161: 105-114. (Pubitemid 34760776)
8. Barrera D, Avila E, Hernandez G, Mendez I, Gonzalez L, Halhali A, Larrea F, Morales A, Diaz L: Calcitriol affects hCG gene transcription in cultured human syncytiotrophoblasts. Reprod Biol Endocrinol 2008; 6: 3.
9. Stumpf WE, Denny ME: Vitamin D (soltriol), light, and reproduction. Am J Obstet Gynecol 1989; 161: 1375-1384. (Pubitemid 20007715)
10. Zehnder D, Bland R, Chana RS, Wheeler DC, Howie AJ, Williams MC, Stewart PM, Hewison M: Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. J Am Soc Nephrol 2002; 13: 621-629. (Pubitemid 34183926)
11. Evans KN, Bulmer JN, Kilby MD, Hewison M: Vitamin D and placental-decidual function. J Soc Gynecol Investig 2004; 11: 263-271. (Pubitemid 38833606)
12. Diaz L, Arranz C, Avila E, Halhali A, Vilchis F, Larrea F: Expression and activity of 25-hydroxyvitamin D-1 alpha-hydroxylase are restricted in cultures of human syncytiotrophoblast cells from preeclamptic pregnancies. J Clin Endocrinol Metab 2002; 87: 3876-3882. (Pubitemid 34879543)
13. Seely EW, Wood RJ, Brown EM, Graves SW: Lower serum ionized calcium and abnormal calciotropic hormone levels in preeclampsia. J Clin Endocrinol Metab 1992; 74: 1436-1440.
14. Halhali A, Tovar AR, Torres N, Bourges H, Garabedian M, Larrea F: Preeclampsia is associated with low circulating levels of insulinlike growth factor I and 1,25-dihydroxyvitamin D in maternal and umbilical cord compartments. J Clin Endocrinol Metab 2000; 85: 1828-1833. (Pubitemid 32269284)
15. Robinson CJ, Alanis MC, Wagner CL, Hollis BW, Johnson DD: Plasma 25-hydroxyvitamin D levels in early-onset severe preeclampsia. Am J Obstet Gynecol 2010; 203: 366.e1-e6.
16. Bodnar LM, Catov JM, Simhan HN, Holick MF, Powers RW, Roberts JM: Maternal vitamin D deficiency increases the risk of preeclampsia. J Clin Endocrinol Metab 2007; 92: 3517-3522. (Pubitemid 47435329)
17. Baker AM, Haeri S, Camargo CA Jr, Espinola JA, Stuebe AM: A nested case-control study of midgestation vitamin D deficiency and risk of severe preeclampsia. J Clin Endocrinol Metab 2010; 95: 5105-5109.
18. Czeizel AE, Rockenbauer M, Siffel C, Varga E: Description and mission evaluation of the Hungarian case-control surveillance of congenital abnormalities, 1980-1996. Teratology 2001; 63: 176-185. (Pubitemid 32417246)
19. Czeizel AE: First 25 years of the Hungarian congenital abnormality registry. Teratology 1997; 55: 299-305. (Pubitemid 27389919)
20. Czeizel AE, Petik D, Vargha P: Validation studies of drug exposures in pregnant women. Pharmacoepidemiol Drug Saf 2003; 12: 409-416. (Pubitemid 36903378)
21. Czeizel AE, Vargha P: Periconceptional folic acid/multivitamin supplementation and twin pregnancy. Am J Obstet Gynecol 2004; 191: 790-794. (Pubitemid 39298111)
22. Cleve H, Bearn AG: Inherited variations in human serum proteins: studies on the groupspecific component. Ann NY Acad Sci 1961; 94: 218-224.
23. Fraser A, Macdonald-Wallis C, Tilling K, Boyd A, Golding J, Davey Smith G, Henderson J, Macleod J, Molloy L, Ness A, Ring S, Nelson SM, Lawlor DA: Cohort profile: the Avon Longitudinal Study of Parents and Children: ALSPAC mothers cohort. Int J Epidemiol 2012; 42: 97-110.
24. Davey DA, MacGillivray I: The classification and definition of the hypertensive disorders of pregnancy. Am J Obstetr Gynecol 1988; 158: 892-898.
25. Tolppanen AM, Fraser A, Fraser WD, Lawlor DA: Risk factors for variation in 25-hydroxyvitamin D(3) and D(2) concentrations and vitamin D deficiency in children. J Clin Endocrinol Metabol 2012; 97: 1202-1210.
26. Fang Y, van Meurs JB, Arp P, van Leeuwen JP, Hofman A, Pols HA, Uitterlinden AG: Vitamin D binding protein genotype and osteoporosis. Calcif Tissue Int 2009; 85: 85-93.
27. Zerwekh JE: Blood biomarkers of vitamin D status. Am J Clin Nutr 2008; 87: 1087S-1091S. (Pubitemid 351549268)
28. Royston P: Multiple imputation of missing values. Stata J 2004; 4: 14.
29. Egger M, Davey Smith G, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634. (Pubitemid 27387172)
30. Powe CE, Seely EW, Rana S, Bhan I, Ecker J, Karumanchi SA, Thadhani R: First trimester vitamin D, vitamin D binding protein, and subsequent preeclampsia. Hypertension 2010; 56: 758-763.
31. Haugen M, Brantsaeter AL, Trogstad L, Ale xander J, Roth C, Magnus P, Meltzer HM: Vitamin D supplementation and reduced risk of preeclampsia in nulliparous women. Epidemiology 2009; 20: 720-726.
32. Azar M, Basu A, Jenkins AJ, Nankervis AJ, Hanssen KF, Scholz H, Henriksen T, Garg SK, Hammad SM, Scardo JA, Aston CE, Lyons TJ: Serum carotenoids and fat-soluble vitamins in women with type 1 diabetes and preeclampsia: a longitudinal study. Diabetes Care 2011; 34: 1258-1264.
33. Fernandez-Alonso AM, Dionis-Sanchez EC, Chedraui P, Gonzalez-Salmeron MD, Perez-Lopez FR: First-trimester maternal serum 25-hydroxyvitamin D(3) status and pregnancy outcome. Int J Gynaecol Obstet 2012; 116: 6-9.
34. Yu CK, Ertl R, Skyfta E, Akolekar R, Nicolaides KH: Maternal serum vitamin D levels at 11-13 weeks of gestation in preeclampsia. J Hum Hypertens 2013; 27: 115-118.
35. Wetta L, Biggio J, Cliver S, Abramovici A, Barnes S, Tita A: Midtrimester vitamin D status is not associated with spontaneous preterm birth prior to 35 weeks. Am J Obstetr Gynecol 2012; 206:S229-S230.
36. Shand AW, Nassar N, Von Dadelszen P, Innis SM, Green TJ: Maternal vitamin D status in pregnancy and adverse pregnancy outcomes in a group at high risk for pre-eclampsia. BJOG 2010; 117: 1593-1598.
37. Wei SQ AF, Hidiroglou N, Sarafin K, Julien P, Wu Y, Luo ZC, Fraser WD: Longitudinal vitamin D status in pregnancy and the risk of pre-eclampsia. Br J Obstetr Gynaecol 2012; 119: 8.
38. Marya RK, Rathee S, Manrow M: Effect of calcium and vitamin D supplementation on toxaemia of pregnancy. Gynecol Obstet Invest 1987; 24: 38-42. (Pubitemid 17097885)
39. People's League of Health: The nutrition of expectant and nursing mothers in relation to maternal and infant mortality and morbidity. J Obstet Gynaecol Br Emp 1946;53:498-509.
40. Theobald GW: Effect of calcium and vitamins A and D on incidence of pregnancy toxemia. Lancet 1937; 1: 1397-1399.
41. Hollis BW, Johnson D, Hulsey TC, Ebeling M, Wagner CL: Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness. J Bone Miner Res 2011; 26: 2341-2357.
42. Aghajafari F, Nagulesapillai T, Ronksley PE, Tough SC, O'Beirne M, Rabi DM: Association between maternal serum 25-hydroxyvitamin D level and pregnancy and neonatal outcomes: systematic review and meta-analysis of observational studies. BMJ 2013; 346:f1169.
43. Tabesh M, Salehi-Abargouei A, Esmaillzadeh A: Maternal vitamin D status and risk of preeclampsia: a systematic review and metaanalysis. J Clin Endocrinol Metabol 2013; 98: 3165-3173.
44. Hollis BW, Wagner CL: Vitamin D and pregnancy: skeletal effects, nonskeletal effects, and birth outcomes. Calcif Tissue Int 2013; 92: 128-139.
45. Hsu P, Santner-Nanan B, Dahlstrom JE, Fadia M, Chandra A, Peek M, Nanan R: Altered decidual DC-SIGN+ antigen-presenting cells and impaired regulatory T-cell induction in preeclampsia. Am J Pathol 2012; 181: 2149-2160.
46. Hewison M: Vitamin D and immune function: autocrine, paracrine or endocrine? Scand J Clin Lab Invest 2012; 243(suppl):92-102.
47. Erlebacher A: Mechanisms of T cell tolerance towards the allogeneic fetus. Nat Rev Immunol 2013; 13: 23-33.
48. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP: 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002; 110: 229-238. (Pubitemid 34787360)
49. Grundmann M, Haidar M, Placzko S, Niendorf R, Darashchonak N, Hubel CA, von Versen-Hoynck F: Vitamin D improves the angiogenic properties of endothelial progenitor cells. Am J Physiol Cell Physiol 2012; 303:C954-C962.
50. Cardus A, Panizo S, Encinas M, Dolcet X, Gallego C, Aldea M, Fernandez E, Valdivielso JM: 1,25-dihydroxyvitamin D3 regulates VEGF production through a vitamin D response element in the VEGF promoter. Atherosclerosis 2009; 204: 85-89.
51. Brosens JJ PR, Brosens IA: The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: a review of the literature. Am J Obstetr Gynecol 2002; 187: 8.
52. Ross et al (eds): Dietary Reference Intakes for Calcium and Vitamin D. Washington, National Academy of Sciences, 2011.
53. Hyppönen E, Boucher BJ: Avoidance of vitamin D deficiency in pregnancy in the United Kingdom: the case for a unified approach in national policy. Br J Nutr 2010; 104: 309-314.